Full history for every metric is available with a Kvantra account
Braster S.A. (BRA.WA)
Key financial summary
Financials in PLN| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | PLN m | 1 | 1 | 0 | 0 | 2 | 0 | 0 |
| Operating profit | PLN m | -4 | -3 | |||||
| Net profit | PLN m | -20 | -16 | -16 | -9 | -4 | -5 | -4 |
| EPS reported | PLN | -0.16 | -0.15 | |||||
| Operating cashflow per share | PLN | 0.04 | 0.04 | |||||
| Capex per share | PLN | 0.00 | 0.00 | |||||
| FCF per share | PLN | 0.04 | 0.04 | |||||
| Free cash flow | PLN m | 1 | 2 | |||||
| Net debt | PLN m | 11 | 12 | |||||
| Book value equity | PLN m | -4 | -5 | |||||
| Book value per share | PLN | -0.15 | -0.17 | |||||
| Number of shares | m | 29.38 | 29.38 | |||||
| DPS (TTM paid) | PLN | 0.00 | 0.00 |
Financial summary
Financials in PLN| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -3.85 | -3.38 | |||||
| P/S LTM | x | 53.42 | 60.01 | |||||
| P/FCF LTM | x | 13.79 | 9.93 | |||||
| EV/EBITDA LTM | x | -18.26 | -20.29 | |||||
| EV/Sales LTM | x | 88.85 | 100.71 | |||||
| Earnings Yield LTM | % | -27.86% | -27.86% | |||||
| FCF Yield | % | 7.25% | 10.07% | |||||
| Quality | ||||||||
| ROE | % | 107.20% | 251.28% | |||||
| ROIC | % | -33.35% | -33.35% | |||||
| Operating margin | % | -1115.7% | -1115.7% | |||||
| Gross margin | % | -496.87% | -496.87% | |||||
| FCF/Sales | % | 387.46% | 387.46% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -85.76% | -86.73% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | 0.00% | +113.97% | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.11 | 0.15 | |||||
| Net Debt/EBITDA | x | -7.28 | -7.28 | |||||
| EBIT/Net interest | x | -2.92 | -2.92 | |||||
| Net debt/market cap | % | 66.32% | 67.83% | |||||
| Net debt/Equity | x | -2.55 | -2.29 | |||||
| Gross debt/equity | x | -2.55 | -2.29 | |||||
Company overview
Braster S.A. globally manufactures and distributes innovative diagnostic devices for at-home breast screening. Its product line includes the Braster System, designed for individual at-home breast examinations, and the Braster Pro, tailored for clinical application by healthcare professionals. Initially operating as BRASTER spólka z ograniczona odpowiedzialnoscia, the firm formally changed its designation to Braster S.A. in December 2012. Established in 2008, Braster S.A. is headquartered in Ozarów Mazowiecki, Poland.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Braster S.A. (BRA.WA)
Braster S.A. globally manufactures and distributes innovative diagnostic devices for at-home breast screening. Its product line includes the Braster System, designed for individual at-home breast examinations, and the Braster Pro, tailored for clinical application by healthcare professionals. Initially operating as BRASTER spólka z ograniczona odpowiedzialnoscia, the firm formally changed its designation to Braster S.A. in December 2012. Established in 2008, Braster S.A. is headquartered in Ozarów Mazowiecki, Poland.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free